There is no definitive clinical evidence that FAP/FAPF in combination with either angiotensin converting enzyme replacement therapy or pravastatin significantly reduces the risk of death from cardiac arrest, which is the primary reason for use of those drugs in patients with HF. We know that, in general, HF can be caused by two separate causes: myocardial infarction or sudden cardiac death from ventricular fibrillation. Therefore, it is hard to predict how a given patient will progress from a primary or secondary cause of HF to sudden cardiovascular death, where all potential treatments are ineffective or ineffective. A new drug with only a one-in-a-million chance of a beneficial outcome may be a very expensive drug, and a drug made to treat a disease that has no known cure, even if it is a better therapeutic option than existing drugs, is unlikely to be adopted. There are other therapies, including drugs that suppress the heart rate by increasing the activity of sympathetic nerve endings and electrical impulses to the heart, which have recently been approved. There is a new drug being studied that may result in a one-in-a-million chance of a beneficial outcome, but even that cannot be considered a certainty due to the small numbers of subjects who may benefit from it.
For those of you who’ve been living under a rock, back in July, one study published in Lancet found that those that smoked cigarettes were 6.6 times more likely to die from heart attack and 22.4 times more likely to die from coronary artery disease than those who did not smoke, an important figure to consider if you’re smoking. Now, while I have absolutely no problem with smoking in itself, I know it is a major contributing factor as far as heart disease and stroke go. Not only that, but the studies to the contrary of that, that you don’t need to smoke a pipe to smoke the cigarette that has the same chemical ingredients in it as the tobacco cigarette and is still the product of the smoker, was one of the things that was so compelling about the study. The findings also confirmed the fact that the same substances found in cigarettes are present in the nicotine patches. And so, with some of these current studies in mind, there’s really no reason why FAP/FAPF should be any different from anything else on the market. And so, as stated in the media as well as in the commentary on the original trial, we could be very safe doing our part to reduce heart disease, and I would be very happy if I could be that one less death (if no one’s dying of heart disease). However, these particular studies from many of the sources cited in this article didn’t have the benefit of smoking and are obviously biased.
So, after our last comment from Dr. Mandrola and I discussed both the lack of efficacy between the individual drug and what’s currently on the market, I thought that we should go ahead and go ahead and have a new drug. I know the process for FDA approval of a drug is arduous, but still one thing remains: this is definitely something that should be done in order to protect the public. I really believe that if we can do it without spending tons of money on needless side effects, that it’d be a great idea. It wouldn’t be too expensive, only 5 to 10 times more expensive, and with the benefits of having more hearts in survival. So, I am going to go ahead and ask for your help and help me with my proposal. The purpose for this thread is to get people talking about this proposal and to make sure that the FDA has the information they need to proceed.
The following points are in no way written and should not be construed as legal advice. I hope you have both read and understood my proposal and all its implications, and if you have not, I am happy to walk you though it. It’s important to keep in mind that I have no vested interest in the treatment of heart disease. I am simply looking for a way that can protect the public from this inevitable burden of disease. If you would prefer not to participate in this effort and I understand that this is an extremely painful decision for you, then please refrain from your comments and stay at your posts until your post has been made public. Once the decision is made, I will post a link to the thread for you to comment on. I know this is a contentious topic that will certainly lead to arguments and disagreement among our group, but again the idea of having a new drug that can prevent the need for other methods of cardiac preservation should not be denied.
So, without further ado, my proposal:
1.- Use a new drug that has only a one-in-a-million chance of a beneficial outcome on the basis of not having a history of